T h e nitric oxide synthases (NOSs) are dimeric flavocytochromes consisting of an oxygenase domain with cytochrome P450-like Cys-ligated haem, coupled to a diflavin reductase domain, which is related to cytochrome P450 reductase. T h e NOSs catalyse the sequential mono-oxygenation of arginine to N-hydroxyarginine and then to citrulline and NO. The constitutive NOS isoforms (cNOSs) are regulated by calmodulin (CaM), which binds at elevated concentrations of free Ca2+, whereas the inducible isoform binds CaM irreversibly. One of the main structural differences between the constitutive and inducible isoforms is an insert of 40-50 amino acids in the FMN-binding domain of the cNOSs. Deletion of the insert in rat neuronal NOS (nNOS) led to a mutant enzyme which binds CaM at lower Ca2+ concentrations and which retains activity in the absence of CaM. In order to resolve the mechanism of action of CaM activation we determined reduction potentials for the F M N and FAD cofactors of rat nNOS in the presence and absence of CaM using a recombinant form of the reductase domain. T h e results indicate that CaM binding does not modulate the reduction potentials of the flavins, but appears to control electron transfer primarily via a large structural rearrangement. We Key words: autoinhibitory domain, cytochrome P450, nitric oxide, protein engineering. Abbreviations used: NOS, nitric oxide synthase; nNOS, iNOS and eNOS, neuronal, induced and endothelial NOS; P450, cytochrome P450; BM3. Bacillus rnegateriurn 111; CaM, calmodulin. 'To whom correspondence should be addressed (e-mail Simon.Daff@ed.ac.uk).
Introduction
Nitric oxide synthases (NOSs) are dimeric flavocytochromes which catalyse the synthesis of NO and citrulline from arginine in two consecutive mono-oxygenation steps [1,2]. There are three main mammalian isoforms which are expressed in specific cell types : neuronal (nNOS), endothelial (eNOS) and macrophage or inducible (iNOS). The NO generated in these cells is involved, respectively, in neurotransmission, regulation of blood flow/pressure and immune response. nNOS and eNOS generate N O to act as a signalling molecule, targeting guanylate cyclase, whereas iNOS produces large amounts of N O to attack proteins and DNA either directly or as peroxynitrite, following combination with superoxide. T h e three isoforms can also be categorized according to their amino acid sequences and regulation mechanisms [3] . The constitutive NOSs (nNOS and eNOS) are regulated by the reversible binding of calmodulin (CaM) through changes in the intracellular Ca2+ concentration. iNOS, however, is expressed with CaM bound permanently and remains active in the absence of free Ca2+ C-terminal reductase domains of the NOSs and consists of 20-25 amino acids (see Figure 1) . Regulation of NOS activity by Ca2+/CaM has been shown to occur via the control of F M N to haem electron transfer across this domain-domain interface [5] . Additionally, CaM has been shown to activate the nNOS reductase domain both within the native dimer and in a mutant consisting of the reductase domain only [6] . As illustrated in Figure 1 , the reductase domains appear to supply electrons to the haem domain of the alternate subunit [7] . . In rat nNOS the size of the insert was determined by sequence alignment with iNOS to be 42 amino acids long. Both mutant enzymes behaved similarly, but the A40 mutant was found to be more stable and to retain its activity longer. This mutant was therefore studied in more detail. Table 1 compares the rates of NO synthesis catalysed by the A40 mutant with those for wild-type nNOS in the presence and absence of Ca2+/CaM. For the wild-type enzyme, NO synthesis could only be observed in the presence of Ca2+/CaM, whereas this was not an absolute requirement for the A40 mutant. Nevertheless, the mutant still responded to the addition of Ca2'/CaM by a 3-fold rate enhancement. Under these conditions, the mutant had around 30% of the activity of the wild-type enzyme, indicating that the insert is involved in stabilizing the conformation of the enzyme required for optimum activity. The fact that the deletion mutants retained activity in the absence of Ca2+/CaM indicates that the insert is also responsible for disabling the enzyme, consistent with its proposed role as an autoinhibitory domain. The reason for this latent activity was clarified by following the reduction of the NOS haem on addition of NADPH under anaerobic conditions. For the wild-type enzyme, haem reduction was found to be negligible in the absence of Ca2+/CaM, whereas under identical conditions the A40 mutant haem was reduced spontaneously. Deletion of the insert appears to reactivate electron transfer across the FMN-haem interface. The A40 mutant did not bind CaM irreversibly, but the concentrations of Ca2+ required for CaM binding were found to be much lower than for wild-type nNOS. Therefore the insert also appears to destabilize CaM binding NO synthesis indicates the rate of NO synthesis in the presence/absence of I mM Ca2+/IOpg.ml-' CaM at 25 "C for nNOS, the A40 mutant and chimaera 111, which contains the nNOS haem domain. NADPH oxidation indicates the rate of NADPH consumption in the presencelabsence of I00 pM arachidonate and/or I mM Ca2+/ I0 pg.rn1-l CaM at 30 "C for 6. megaterium 111 cytochrome P450 (P450 BM3) and chimaeras I and 11, which contain the BM3 haem domain. Chimaeras I, II and 111 are defined in the text.
Deletion of the putative autoinhibitory domain of nNOS
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- and it seems likely that the structure of the insert may help to determine the Ca2+ sensitivity of the different NOS isoforms. A similar study involving the deletion of the corresponding region of eNOS also led to mutant enzymes with greater affinity for Ca2+ [13], but for these, no activity was detected in the absence of CaM. T h e probable role of the nNOS autoinhibitory insert is depicted in Figure  1 . When CaM is not bound, the insert appears to inhibit electron transfer both from F M N to haem and through the reductase domain. CaM binding repositions the domains and activates the enzyme by displacing the insert. In iNOS and the A40 mutant the autoinhibitory region is missing and therefore there is less impediment to both CaM binding and interdomain electron transfer.
Does CaM binding control the flavin domain redox potentials?
CaM is therefore ideally placed to accept electrons from the F M N hydroqinone, which has a reduction potential of around -270 mV. T h e reduction potential of the nNOS haem was found to be largely independent of arginine binding, whereas the iNOS haem appears to undergo a shift in potential from -295 mV to -263 mV, i.e. bringing it within range of the reductase domain FMN. This may constitute a substrate-dependent electron-transfer switch analogous to the mechanism of activation of cytochrome P450 (P450) enzymes. For nNOS, electrons will be supplied to the haem whether or not substrate is bound and, in fact, steady-state consumption of NADPH by wild-type nNOS is faster in the absence of substrate [12] . However, electron transfer from F M N to haem is only possible in the presence of Ca2+/CaM and in nNOS this acts as the primary regulation mechanism.
It appears therefore, that in nNOS, the role of CaM is to bring the F M N and haem close enough together to initiate electron transfer by inducing a large structural rearrangement. Certainly, the increase in reductase activity observed on CaM binding is not caused by a rearrangement in flavin reduction potentials. Recent reports indicate that CaM binding affects the FAD domain and primarily influences the rate of FAD reduction by NADPH. In support of this, a further structural element involved in kinetic control of the reductase domain has been identified at the nNOS C-terminus [17] .
Swapping the reductase domains of Bacillus megaterium 111 (BM3) P450 and rat nNOS
T h e reductase domain of the NOSs closely resembles the soluble fragment of mammalian microsomal P450 reductase, a membrane-bound flavoenzyme that supplies electrons to an array of membrane-bound P450s. T h e catalytically selfsufficient NOSs appear to have arisen from the fusion of a similar gene to one for the NOS oxygenase domain [18] . Only a few similar selfcontained P450 systems have been discovered ; these are exemplified by the bacterial flavocytochrome, P450 BM3. This enzyme boasts the fastest steady-state turnover rates of any known P450 system (Table 2) , probably as a result of it being a single-component system [19] . Intriguingly, P450 BM3 has a very different ordering of F M N reduction potentials (Table 1) [20] . It seems likely that the F M N transfers electrons from FAD to haem via a thermodynamically unstable red F M N semiquinone free radical, although the reason for this is unclear. In order to determine if the reductase domain of P450 BM3 could be used to drive NO synthesis, a chimaeric enzyme (chimaera I) was generated consisting of residues 1-756 of rat nNOS (i.e. the oxygenase domain and CaM-binding site) fused to residues 485-1049 of P450 BM3 (i.e. the reductase domain). This mutant enzyme was expressed in Escherichia coli using the same pCWori expression system used to express wild-type nNOS [21] and purified using a similar protocol. Two alternative chimaeras were also generated: chimaera I1 consisted of residues 1-458 of P450 BM3 (the oxygenase domain) fused to residues 724-1429 of rat nNOS (the CaM-binding site and reductase domain). Chimaera I11 consisted of residues 1 4 5 8 of P450 BM3 (the oxygenase domain) fused to residues 6741429 of rat nNOS (the CaM-binding site with extended hinge and reductase domain).
Both were expressed in E. coli in the same way as wild-type P450 BM3 and purified using a similar protocol [22] . T h e haem domain of chimaera I proved to be unstable relative to that of wild-type nNOS, purifying with around 80 yo of the haem in the cysteine-detached P420 form. Chimaeras I1 and I I I formed stable flavocytochromes with characteristic P450 BM3 CO-reduced spectra. T h e reductase domains of the chimaeras functioned normally, catalysing cytochrome c reduction at similar rates to their parent wild-type enzymes, although, in the case of chimaeras I1 and 111, with much less Ca2+/CaM dependence. T h e haems of chimaeras I1 and I11 both underwent low-to-high spin-state shifts on addition of the P450 BM3 substrate arachidonate, with Kd values of 4.9 p M and 5 pM respectively, which are similar to that of wild-type P450 BM3 (4.2 pM). Rates of NO synthesis were determined for chimaera I using the 2,3-diaminonaphthalene assay kit, directly after purification (Table 1) . T h e rates are lower than those for wild-type and A40 mutant nNOS, but nevertheless are significant. Like the A40 mutant, chimaera I retains some activity in the absence of Ca2+/CaM. This is presumably because the P450 BM3 reductase domain present in chimaera I does not contain an autoinhibitory loop. T h e FMN-binding region and haem domain must therefore be free to interact in a catalytically productive manner. In the presence of Ca2+/CaM, the rate of N O synthesis catalysed by chimaera I is doubled, this change is of similar magnitude to the one observed in the A40 mutant. It appears, therefore, that the reductase domain of P450 BM3 can provide the reducing equivalents for NO synthesis and is similar to the nNOS A40mutant in its Ca2+/CaM dependence. A comparison between the rates of turnover for P450 BM3 and those of chimaeras I1 and I11 are also shown in Table 1 . In the absence of substrate (arachidonate) the enzymes catalyse NADPH consumption at similar low levels, much of which is due to the reaction of oxygen with the reductase domain. However, the rate enhancement on addition of arachidonate gives an indication of the rate at which electrons are being delivered to the P450 haem domain. For wild-type P450 BM3 the increase is dramatic, resulting from the spin-state change and reduction potential shift occurring on substrate binding. For the chimaeric enzymes, the same shift in spin state occurs; however, the rate enhancement is much less. When Ca2+/CaM is included in the assay for chimaeras I1 and I11 the rate of turnover doubles, probably due to an increase in the activity of the reductase domain. However, direct electron transfer to the haem of chimaera I11 was observed under anaerobic conditions and was found to be Ca2+/CaM dependent. Overall, it appears that the slow rate of electron supply to the haem domain in chimaeras I I and I I I impairs turnover with arachidonate, indicating that the nNOS reductase domain is not compatible with the BM3 haem domain. The problem must lie in either the driving force for flavin-to-haem electron transfer being insufficient or in a lack of structural compatibility. T h e first reason would explain why flavocytochrome P450 BM3 has unusual F M N reduction potentials and utilizes an unstable anionic semiquinone species as electron donor rather than the stable reduced hydroquinone found in microsoma1 P450 reductase and NOS. A lack of structural compatibility between the nNOS reductase and the BM3 haem domain, possibly caused by the nNOS autoinhibitory loop, may prevent the two domains forming a viable electron-transfer complex.
